Clinical trials
Phase 2 Hepatoblastoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 7 |
| 2018 | 4 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 10 |
| Completed | 10 |
| Recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 16 |
| Children's Oncology Group | 2 |
| Children's Cancer and Leukaemia Group | 1 |
| Children's National Research Institute | 1 |
| Instituto do Cancer do Estado de São Paulo | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| Sun Yat-sen University | 1 |
| University of Leicester | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatoblastoma | 25 |
| Neuroblastoma | 21 |
| Osteosarcoma | 21 |
| Neuroectodermal Tumors, Primitive, Peripheral | 17 |
| Rhabdomyosarcoma | 17 |
| Wilms Tumor | 17 |
| Sarcoma | 16 |
| Ependymoma | 13 |
| Glioma | 13 |
| Histiocytosis, Langerhans-Cell | 13 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.